C. R. BardStock Price and Value Analysis

Should you buy C. R. Bard stock? (NYSE:BCR). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company is very stable.
  • This company is making money at a great rate!
  • This company has stable growth.
  • This company has a low dividend yield.
  • This stock looks overpriced.

BCR Free Cash Flow Trend

Based on historical returns, we believe that C. R. Bard can grow its free cash at a rate of about 11%. That's positive!

Free Cash Flow trendline for BCR
Free Cash Flow trendline for C. R. Bard

Inside the BCR Numbers

BCR Price
(C. R. Bard stock price per share)
$332.10
[?] BCR Fair Price
(based on intrinsic value)
$140.65
[?] BCR Safety Price (based on a variable margin of safety) $112.52
[?] PE Ratio versus Sector 116% higher than other Healthcare stocks
[?] PE Ratio versus Industry 81% higher than other Medical Instruments & Supplies stocks
[?] Cash Yield 3.66%
[?] Free Cash Flow Jitter 19%
[?] Dividend Yield 0%

Is C. R. Bard Stock on Sale?

We believe that C. R. Bard may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

C. R. Bard looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy BCR Stock?

Does C. R. Bard have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.